ArticleBioengineered2022

HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.

Donglin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.